0001209191-22-057005.txt : 20221115
0001209191-22-057005.hdr.sgml : 20221115
20221115163200
ACCESSION NUMBER: 0001209191-22-057005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221110
FILED AS OF DATE: 20221115
DATE AS OF CHANGE: 20221115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aftab Blake
CENTRAL INDEX KEY: 0001886986
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38359
FILM NUMBER: 221391603
MAIL ADDRESS:
STREET 1: C/O ADICET BIO, INC.
STREET 2: 200 CLARENDON STREET, FLOOR 6
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adicet Bio, Inc.
CENTRAL INDEX KEY: 0001720580
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813305277
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 BERKELEY STREET
STREET 2: 19TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-482-2333
MAIL ADDRESS:
STREET 1: 200 BERKELEY STREET
STREET 2: 19TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: resTORbio, Inc.
DATE OF NAME CHANGE: 20171024
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-11-10
0
0001720580
Adicet Bio, Inc.
ACET
0001886986
Aftab Blake
C/O ADICET BIO, INC.
200 BERKELEY STREET, 19TH FLOOR
BOSTON
MA
02116
0
1
0
0
Chief Scientific Officer
Common Stock
2022-11-10
4
S
0
6967
21.00
D
28209
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
/s/ Nick Harvey, Attorney-in-Fact
2022-11-15